Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pangraf 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Panacea Biotec Pharma Ltd

Salt Composition

Tacrolimus (0.03% w/w)

Overview Pangraf 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacrolimus 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply this topical ointment 2–4 times daily to affected areas, or as directed by your physician. Gently and evenly rub it in. Avoid over-application and occlusive dressings. Consult your doctor if symptoms worsen or show no improvement after a fortnight. Potential side effects include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and erythema. Generally, this medication isn't recommended during pregnancy or lactation unless deemed essential by your healthcare provider.

Primary Ingredients of Pangraf 0.03% Ointment

No text provided. Please provide the text you want me to rephrase.

Uses of Pangraf 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Pangraf 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected skin is clean and dry before gently rubbing in the cream.

Common Side effects of Pangraf 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Pangraf 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always refer to the product label for application guidelines. Ensure the affected skin is clean and dry before gently rubbing in the cream.

How Pangraf 0.03% Ointment works:

Tacrolimus 0.03% topical ointment, an immunosuppressant medication, reduces skin inflammation by inhibiting the action of specific immune cells. This action alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No drug interactions identified.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pangraf 0.03% Ointment during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Use of 0.03% Pangraf Ointment while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No drug interaction detected.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Pangraf 0.03% Ointment :

Delayed application of Pangraf 0.03% Ointment? Apply the missed dose immediately unless your next scheduled application is imminent; in that case, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Pangraf 0.03% Ointment

LabelValue
Chemical Type Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Category Calcineurin inhibitor immunosuppressants

FAQs on Pangraf 0.03% Ointment

Pangraf 0.03% Ointment is an immunosuppressant used to treat moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to, or adversely affected by, steroid treatments. Atopic dermatitis involves an overactive immune system causing skin inflammation, itchiness, redness, and dryness. Pangraf 0.03% Ointment modifies this abnormal immune response, reducing inflammation and itching.
Applying Pangraf 0.03% Ointment topically may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash. These side effects usually subside within a week. Treatment also increases the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Pangraf 0.03% Ointment offers safe and effective short-term atopic dermatitis treatment, exhibiting superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral administration.
Pangraf 0.03% Ointment is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Pangraf 0.03% Ointment may increase the risk of lymphoma, a type of lymph node tumor. Studies indicate a link between this ointment (or similar medications) and the development of skin cancer or lymphoma in a small number of patients. If using Pangraf 0.03% Ointment for over six weeks, or if your eczema worsens or fails to improve, consult your doctor.
Pangraf 0.03% Ointment is a non-steroidal medication that modulates the immune system. It treats eczema, particularly atopic dermatitis, without the skin thinning or other side effects associated with steroids.
Pangraf 0.03% Ointment
86
MRP 105
18% off